I 
117TH CONGRESS 
1ST SESSION H. R. 1384 
To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) 
to eliminate the separate registration requirement for dispensing narcotic 
drugs in schedule III, IV, or V (such as buprenorphine) for maintenance 
or detoxification treatment, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 25, 2021 
Mr. TONKO (for himself, Mr. TURNER, Mr. DELGADO, Mr. GONZALEZ of Ohio, 
Ms. BARRAGA´N, Ms. BASS, Ms. BLUNT ROCHESTER, Ms. BROWNLEY, 
Mr. CARBAJAL, Mr. CA´RDENAS, Mr. CASE, Ms. CLARKE of New York, 
Mr. RODNEY DAVIS of Illinois, Ms. DEAN, Mr. GALLEGO, Mr. HASTINGS, 
Mr. HIGGINS of New York, Mr. FITZPATRICK, Ms. JAYAPAL, Mr. JONES, 
Mr. KATKO, Mr. KIM of New Jersey, Ms. KUSTER, Mr. LAWSON of Flor-
ida, Mr. LEVIN of California, Ms. MATSUI, Mr. MEEKS, Mr. NADLER, 
Mrs. NAPOLITANO, Ms. NORTON, Mr. O’HALLERAN, Mr. PASCRELL, Mr. 
PAYNE, Ms. PINGREE, Mr. RASKIN, Miss RICE of New York, Ms. SCAN-
LON, Mr. SCHRADER, Mr. SMITH of Washington, Ms. STRICKLAND, Mr. 
SUOZZI, Mr. TAYLOR, Mr. TRONE, Ms. UNDERWOOD, Mrs. WATSON 
COLEMAN, Mr. WELCH, Ms. WILD, and Ms. ADAMS) introduced the fol-
lowing bill; which was referred to the Committee on Energy and Com-
merce, and in addition to the Committees on Ways and Means, and the 
Judiciary, for a period to be subsequently determined by the Speaker, in 
each case for consideration of such provisions as fall within the jurisdic-
tion of the committee concerned 
A BILL 
To amend section 303(g) of the Controlled Substances Act 
(21 U.S.C. 823(g)) to eliminate the separate registration 
requirement for dispensing narcotic drugs in schedule 
III, IV, or V (such as buprenorphine) for maintenance 
or detoxification treatment, and for other purposes. 
VerDate Sep 11 2014 
15:43 Mar 24, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6652
E:\BILLS\H1384.IH
H1384
pamtmann on DSKBC07HB2PROD with BILLS
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Mainstreaming Addic-
tion Treatment Act of 2021’’. 
SEC. 2. ELIMINATING SEPARATE REGISTRATION REQUIRE-
MENT FOR DISPENSING NARCOTIC DRUGS IN 
SCHEDULE III, IV, AND V FOR MAINTENANCE 
OR DETOXIFICATION TREATMENT. 
(a) IN GENERAL.—Section 303 of the Controlled 
Substances Act (21 U.S.C. 823) is amended— 
(1) by striking paragraph (2) of subsection (g); 
and 
(2) in subsection (g), as amended— 
(A) by striking ‘‘(g)(1) Except as provided 
in paragraph (2), practitioners who dispense 
narcotic drugs to individuals for maintenance 
treatment or detoxification treatment’’ and in-
serting ‘‘(g) Practitioners who dispense narcotic 
drugs (other than narcotic drugs in schedule 
III, IV, or V) to individuals for maintenance 
treatment or detoxification treatment’’; 
(B) by redesignating subparagraphs (A), 
(B), and (C) as paragraphs (1), (2), and (3), 
respectively; and 
VerDate Sep 11 2014 
15:43 Mar 24, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1384.IH
H1384
pamtmann on DSKBC07HB2PROD with BILLS
(C) in paragraph (2), as redesignated, by 
redesignating clauses (i) and (ii) as subpara-
graphs (A) and (B), respectively. 
(b) CONFORMING CHANGES.— 
(1) Subsections (a) and (d)(1) of section 304 of 
the Controlled Substances Act (21 U.S.C. 824) are 
amended by striking ‘‘303(g)(1)’’ each place it ap-
pears and inserting ‘‘303(g)’’. 
(2) Section 309A(a)(2) of the Controlled Sub-
stances Act (21 U.S.C. 829a) is amended— 
(A) in the matter preceding subparagraph 
(A), by striking ‘‘the controlled substance is to 
be administered for the purpose of maintenance 
or 
detoxification 
treatment 
under 
section 
303(g)(2)’’ and inserting ‘‘the controlled sub-
stance is a narcotic drug in schedule III, IV, or 
V to be administered for the purpose of mainte-
nance or detoxification treatment’’; and 
(B) by striking ‘‘and—’’ and all that fol-
lows through ‘‘is to be administered by injection 
or implantation;’’ and inserting ‘‘and is to be 
administered by injection or implantation;’’. 
(3) Section 520E–4(c) of the Public Health 
Service Act (42 U.S.C. 290bb–36d(c)) is amended 
by striking ‘‘information on any qualified practi-
VerDate Sep 11 2014 
15:43 Mar 24, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1384.IH
H1384
pamtmann on DSKBC07HB2PROD with BILLS
tioner that is certified to prescribe medication for 
opioid dependency under section 303(g)(2)(B) of the 
Controlled Substances Act’’ and inserting ‘‘informa-
tion on any practitioner who prescribes narcotic 
drugs in schedule III, IV, or V of section 202 of the 
Controlled Substances Act for the purpose of main-
tenance or detoxification treatment’’. 
(4) Section 544(a)(3) of the Public Health 
Service Act (42 U.S.C. 290dd–3) is amended by 
striking ‘‘any practitioner dispensing narcotic drugs 
pursuant to section 303(g) of the Controlled Sub-
stances Act’’ and inserting ‘‘any practitioner dis-
pensing narcotic drugs for the purpose of mainte-
nance or detoxification treatment’’. 
(5) Section 1833(bb)(3)(B) of the Social Secu-
rity Act (42 U.S.C. 1395l(bb)(3)(B)) is amended by 
striking ‘‘first receives a waiver under section 303(g) 
of the Controlled Substances Act on or after Janu-
ary 1, 2019’’ and inserting ‘‘first begins prescribing 
narcotic drugs in schedule III, IV, or V of section 
202 of the Controlled Substances Act for the pur-
pose of maintenance or detoxification treatment on 
or after January 1, 2021’’. 
(6) Section 1834(o)(3)(C)(ii) of the Social Se-
curity Act (42 U.S.C. 1395m(o)(3)(C)(ii)) is amend-
VerDate Sep 11 2014 
15:43 Mar 24, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1384.IH
H1384
pamtmann on DSKBC07HB2PROD with BILLS
ed by striking ‘‘first receives a waiver under section 
303(g) of the Controlled Substances Act on or after 
January 1, 2019’’ and inserting ‘‘first begins pre-
scribing narcotic drugs in schedule III, IV, or V of 
section 202 of the Controlled Substances Act for the 
purpose of maintenance or detoxification treatment 
on or after January 1, 2021’’. 
(7) Section 1866F(c)(3) of the Social Security 
Act (42 U.S.C. 1395cc–6(c)(3)) is amended— 
(A) in subparagraph (A), by inserting 
‘‘and’’ at the end; 
(B) in subparagraph (B), by striking ‘‘; 
and’’ and inserting a period; and 
(C) by striking subparagraph (C). 
(8) Section 1903(aa)(2)(C) of the Social Secu-
rity Act (42 U.S.C. 1396b(aa)(2)(C)) is amended— 
(A) in clause (i), by inserting ‘‘and’’ at the 
end; and 
(B) by striking clause (ii). 
SEC. 3. NATIONAL EDUCATION CAMPAIGN. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services, acting through the Assistant Secretary 
for Mental Health and Substance Use, shall conduct a na-
tional campaign to educate practitioners with respect to 
the elimination of the separate registration requirement 
VerDate Sep 11 2014 
15:43 Mar 24, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H1384.IH
H1384
pamtmann on DSKBC07HB2PROD with BILLS
under section 303(g) of the Controlled Substances Act (21 
U.S.C. 823(g)), as in effect on the day before the date 
of enactment of this Act, for dispensing narcotic drugs in 
schedule III, IV, and V for maintenance or detoxification 
treatment. 
(b) REQUIRED COMPONENTS.—The national edu-
cation campaign under subsection (a) shall— 
(1) encourage practitioners to integrate sub-
stance use treatment into their practices; and 
(2) include education on publicly available edu-
cational resources and training modules that can as-
sist practitioners in treating patients with a sub-
stance use disorder. 
SEC. 4. COMMUNITY HEALTH AIDES AND COMMUNITY 
HEALTH PRACTITIONERS. 
(a) PRACTICE OF TELEMEDICINE.—Section 102 of 
the Controlled Substances Act (21 U.S.C. 802) is amend-
ed— 
(1) in paragraph (54)(A), by striking clause (i) 
and inserting the following: 
‘‘(i) while the patient is— 
‘‘(I) being treated by, and physically 
located in, a hospital or clinic registered 
under section 303(f); or 
VerDate Sep 11 2014 
15:43 Mar 24, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H1384.IH
H1384
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(II) for purposes of section 302(h), 
being treated by a community health aide 
or community health practitioner; and’’; 
(2) by redesignating paragraph (58) as para-
graph (59); 
(3) by redesignating the second paragraph des-
ignated as paragraph (57) as paragraph (58); 
(4) by moving paragraphs (57), (58) (as so re-
designated), and (59) (as so redesignated) 2 ems to 
the left; and 
(5) by adding at the end the following: 
‘‘(60) The terms ‘community health aide’ and ‘com-
munity health practitioner’ have the meanings given to 
such terms for purposes of section 119 of the Indian 
Health Care Improvement Act (25 U.S.C. 1616l).’’. 
(b) DISPENSATION OF NARCOTIC DRUGS IN SCHED-
ULE III, IV, OR V.—Section 302 of the Controlled Sub-
stances Act (21 U.S.C. 822) is amended by adding at the 
end the following: 
‘‘(h) DISPENSATION OF NARCOTIC DRUGS IN SCHED-
ULE III, IV, OR V BY CERTAIN PRACTITIONERS.— 
‘‘(1) IN GENERAL.—Notwithstanding subsection 
(a)(2), a community health aide or community 
health practitioner may dispense a narcotic drug in 
schedule III, IV, or V, such as buprenorphine, or a 
VerDate Sep 11 2014 
15:43 Mar 24, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H1384.IH
H1384
pamtmann on DSKBC07HB2PROD with BILLS
combination of such drugs, to an individual for 
maintenance treatment or detoxification treatment 
(or both) without being registered under this title if 
the drug is prescribed by a practitioner through the 
practice of telemedicine. 
‘‘(2) PREEMPTION.—Notwithstanding section 
708, a State may not require a community health 
aide or community health practitioner to be licensed 
by the State in order to dispense narcotic drugs in 
accordance with paragraph (1) of this subsection.’’. 
Æ 
VerDate Sep 11 2014 
15:43 Mar 24, 2021
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H1384.IH
H1384
pamtmann on DSKBC07HB2PROD with BILLS